NEW YORK, May 8, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) a biopharmaceutical company with small molecule and synthetic biology approaches to new cancer therapies, today announced that it has appointed Jason A. Amello as Executive Vice President and Chief Financial Officer of the Company. In this position, Mr. Amello will lead ZIOPHARM’s financial and capital markets activities, as well as advise on business development and transactional activities, and report to Jonathan Lewis, M.D., Ph.D., Chief Executive Officer of ZIOPHARM.
